Načítá se...
Repositioning of Hypoglycemic Drug Linagliptin for Cancer Treatment
BACKGROUND: Drug repositioning, development of new uses for marketed drugs, is an effective way to discover new antitumor compounds. In this study, we used a new method, filtering compounds via molecular docking to find key targets combination. METHODS: The data of gene expression in cancer and norm...
Uloženo v:
| Vydáno v: | Front Pharmacol |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Frontiers Media S.A.
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7062795/ https://ncbi.nlm.nih.gov/pubmed/32194417 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.00187 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|